RCKT Rocket Pharmaceuticals

添加自选

23.470
+0.700+3.07%

收盘价 05/03 16:00 (美东)

23.659
+0.189+0.80%

盘后 17:30 (美东)

21.30亿总市值-8037市盈率TTM

关于Rocket Pharmaceuticals公司

Rocket Pharmaceuticals Inc 是一家后期生物制药公司。公司专注于开发罕见和毁灭性儿科疾病的基因疗法。公司的渠道产品包括用于Danaon病的RP-A501、用于范可尼贫血的RP-L102、用于白细胞粘附的RP-L201、用于丙酮酸激酶缺乏症的RP-L301和用于婴儿恶性骨质疏松症的RP-L401。

公司介绍

公司代码RCKT

公司名称Rocket Pharmaceuticals

上市日期2015/02/18

发行价格6.00

成立日期1999

CEODr. Gaurav Shah, M.D.

所属市场纳斯达克

员工数量268

证券类型海外普通股

年结日12-31

公司地址9 Cedarbrook Drive

城市Cranbury

省份新泽西

国家美国

邮编08512

电话1-609-659-8001

网址http://www.rocketpharma.com

董事高管

姓名
职务
年薪

Dr. Gaurav Shah, M.D.
Director and Chief Executive Officer
801.36万

Martin Wilson, J.D.
Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
--

Jonathan Schwartz, M.D.
Chief Medical Officer and Chief Gene Therapy Officer
315.78万

Aaron Ondrey
Chief Financial Officer
--

Mayo Pujols
Chief Technical Officer and Executive Vice President
437.77万

Dr. Kinnari Patel, M.B.A.,Pharm.D.
President, Chief Operating Officer and Head of R&D
484.61万

Raj Prabhakar
Chief Business Officer and Senior Vice President
--

Mark White
General Manager, Commercial Affairs
--

John Militello, C.P.A.
Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
152.76万

Dr. Roderick Wong, M.D.
Chairman of the Board
41.00万

David P. Southwell
Independent Director
40.00万

Carsten Boess
Independent Director
42.75万

Dr. Fady Ibraham Malik, M.D.,PhD
Independent Director
40.00万

Dr. Elisabeth Bjork, M.D.,PhD
Independent Director
41.00万

Dr. Gotham Makker, M.D.
Independent Director
40.00万

Robert Keith Woods
Independent Director
56.87万

Pedro P. Granadillo
Independent Director
43.00万

Dr. Naveen Yalamanchi, M.D.
Independent Director
41.75万

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度